HR 3974
116th Congress
House
Health
Criminal justice information and records
Drug trafficking and controlled substances
Health information and medical records
Health personnel
Intergovernmental relations
Licensing and registrations
Medical ethics
Prescription drugs
State and local government operations
Prescription Drug Monitoring Act of 2019
Introduced: July 25, 2019
See on congress.gov
Everywhere this bill has been
3 steps
Introduced
In committee
Reported out
Passed House
Passed Senate
To President
Became law
Jul 26, 2019
Referred to the Subcommittee on Health.
Jul 25, 2019
Referred to the House Committee on Energy and Commerce.
Jul 25, 2019
Introduced in House
Plain-English summary
Prescription Drug Monitoring Act of 2019
This bill expands the notification and reporting requirements with respect to potentially addictive prescription drugs for states receiving funds for a Prescription Drug Monitoring Program (PDMP). Dispensers of these drugs, which includes substances listed in schedule II, III, or IV of the Controlled Substances Act, must consult with the PDMP before starting treatment involving such drugs and report each prescription of such drugs to the PDMP within 24 hours.
The state agency administering a PDMP must analyze reported data for patterns of controlled substance misuse or abuse and provide certain information to law enforcement, the public, and other states.
What's happening now
Referred to the Subcommittee on Health.
Committees of jurisdiction
2